RYAH Group (CSE: RYAH) has named Jules Gagnon as its AVP of investor relations, a role that includes responsibility for coordinating the company’s efforts to communicate and engage with investors. Gagnon has garnered impressive experience and a strong network of investors and capital market participants to the new role, and will direct activities on various social media platforms, including LinkedIn and Twitter. The company stated that Gagnon Jules has a unique set of communication skills, understanding of investors and marketing strategies that will be valuable to the growth of this company, noting that the new AVP will “connect us with valuable capital markets, establish relationships with new long-term investors, and improve engagement with investors in general.” In addition, the company announced that it has closed on part of its proposed private placement of subordinated voting share units; the units were sold at a price of $0.03 per share unit, resulting in RYAH raising $255,000 through the issuance of 8,500,000 share units; the company anticipates using the funds for working capital and will continue its efforts to raise additional capital. “I’m delighted to be a part of RYAH Group at such a pivotal moment for the company,” said RYAH AVP of investor relations Jules Gagnon in the press release. “Until now, RYAH has been mostly recognized as a medical device and software company, through various partnerships with clinical groups. Moving forward, not only will the company continue helping the scientific community make plant-based medical breakthroughs, RYAH will become a global lifestyle brand that will provide any individual with wellness solutions to cater to specific needs. My goal is to help the investment community understand the company’s revised strategic approach, as well as our medium- to long-term trajectory toward profitable growth.”
To view the full press release, visit https://ibn.fm/VaHRM
About RYAH Group Inc.
RYAH is a big data and technology company enabling valuable AI-powered predictive analytics of the efficacy of plant-based medicines and other nutraceuticals administered through its range of innovative IoT-connected medical devices including inhalers, patches and pens. RYAH’s robust big data platform, the only one of its kind in this space, aggregates and analyzes HIPAA-compliant patient data, helping doctors and patients personalize treatments, control dosages, and better predict and monitor outcomes. Beyond specific medical uses, RYAH supports the use of a variety of nutraceuticals by users for wellness purposes, including personal enjoyment, i.e., recreational use. The collection and analyses of objective and subjective usage data, along with data derived through natural language processing of various scientific and other relevant literatures, will enable highly valuable insights for a wide variety of stakeholders, starting with the users themselves, and extending to clinicians, medical scientists, insurance providers, dispensaries, licensed growers, producers, pharmaceutical producers and more. Through the above, a relentless focus on innovation and track record of developing win-win collaborative partnerships within relevant industries, RYAH is continuously building a unique and highly valuable IP portfolio and big data assets ready to be monetized. For more information about the company, please visit www.RyahGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
